Last reviewed · How we verify
Activated T lymphocyte — Competitive Intelligence Brief
phase 2
T cell activator
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
Activated T lymphocyte (Activated T lymphocyte) — GC Cell Corporation. Activated T lymphocytes are a type of immune cell that play a key role in the body's defense against infection and disease.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Activated T lymphocyte TARGET | Activated T lymphocyte | GC Cell Corporation | phase 2 | T cell activator |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (T cell activator class)
- GC Cell Corporation · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Activated T lymphocyte CI watch — RSS
- Activated T lymphocyte CI watch — Atom
- Activated T lymphocyte CI watch — JSON
- Activated T lymphocyte alone — RSS
- Whole T cell activator class — RSS
Cite this brief
Drug Landscape (2026). Activated T lymphocyte — Competitive Intelligence Brief. https://druglandscape.com/ci/activated-t-lymphocyte. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab